Breaking News Instant updates and real-time market news.

LLY

Eli Lilly

$115.67

-0.32 (-0.28%)

, LOXO

Loxo Oncology

$232.56

0.055 (0.02%)

15:32
01/11/19
01/11
15:32
01/11/19
15:32

Lilly CEO says will leave CAR-T therapies to others, Reuters says

Eli Lilly (LLY) CEO Dave Ricks said that the company will leave CAR-T therapies for cancer and gene therapies for rare diseases to others, as the company seeks deals to enhance its pipeline of future treatments, Reuters reports. "The data is amazing, but practically, it's not reaching many people," Ricks said of CAR-T therapy in an interview with Reuters. The comments come after the company announced an $8B purchase of Loxo Oncology (LOXO) this week, the report says. Reference Link

LLY

Eli Lilly

$115.67

-0.32 (-0.28%)

LOXO

Loxo Oncology

$232.56

0.055 (0.02%)

  • 14

    Jan

  • 28

    Jan

  • 18

    May

LLY Eli Lilly
$115.67

-0.32 (-0.28%)

12/27/18
ARGS
12/27/18
NO CHANGE
Target $135
ARGS
Buy
Argus sees volume growth, expanded indications as 2019 catalysts for Eli Lilly
Argus analyst David Toung kept his Buy rating and $135 price target on Eli Lilly, saying its 2019 catalysts for upside include anticipated volume growth and expanded indications for existing drugs, along with "potential regulatory approvals". The analyst notes that while the company's mature products are seeing slower sales and face patent expiration and the loss of exclusivity, he also expects Eli Lilly to generate earnings growth from margin expansion. Toung is also confident in 2019 contribution of Eli Lilly's recently launched Olumiant for rheumatoid arthritis, Verzenio for the second-line treatment of breast cancer, and Taltz for active psoriatic arthritis.
12/31/18
CANT
12/31/18
NO CHANGE
Target $53
CANT
Overweight
Doctors impressed by tanezumab data, says Cantor Fitzgerald
Cantor Fitzgerald analyst Louise Chen says that investors she's spoken with are expecting the data for Pfizer (PFE) and Eli Lilly's (LLY) tanezumab in the first half of 2019 to be similar to or worse than what was seen in the first Phase 3 data set reported on October 23. However, physicians are impressed by the data and do not believe the rapidly progressive osteoarthritis imbalance would impact their desire to prescribe tanezumab if it is approved, Chen tells investors in a research note. The analyst believes the safety for tanezumab will be better than expected and that the drug could replace opioids for the treatment of pain. If that is right, peak sales potential of tanezumab could be billions of dollars, and drive upside to modest expectations for the drug, says the analyst. She keeps an Overweight rating on Pfizer with a $53 price target.
01/07/19
PIPR
01/07/19
NO CHANGE
Target $235
PIPR
Overweight
Piper Jaffray views price paid for Loxo by Eli Lilly as fair
Piper Jaffray analyst Tyler Van Buren views the price of $235 per share paid by Eli Lilly (LLY) for Loxo Oncology (LOXO) as fair. The analyst says the price is near the $250-plus he previously thought was achievable in an acquisition scenario for Loxo. Other names in the precision medicine/oncology space that could be up today as a result of the buyout are Agios Pharmaceuticals (AGIO), ArQule (ARQL), Array BioPharma (ARRY), Blueprint Medicines (BPMC), Kura Oncology (KURA), Mirati Therapeutics (MRTX) and others, Van Buren tells investors in a research note. He raised his price target for Loxo Oncology to $235 from $200 and keeps an Overweight rating on the shares.
01/08/19
SBSH
01/08/19
DOWNGRADE
Target $235
SBSH
Neutral
Loxo Oncology downgraded to Neutral from Buy at Citi
Citi analyst Yigal Nochomovitz downgraded Loxo Oncology (LOXO) to Neutral saying the company is unlikely to receive a competing takeover bid. The analyst raised his price target for the shares to $235 from $201 to reflect the takeover agreement by Eli Lilly (LLY). He believes Mirati Therapeutics (MRTX) is another potential takeover candidate in the oncology space.
LOXO Loxo Oncology
$232.56

0.055 (0.02%)

11/27/18
STFL
11/27/18
NO CHANGE
Target $230
STFL
Buy
Bayer's pricing for Vitrakvi 'breaking paradigm,' but justified, says Stifel
After the FDA granted accelerated approval to Loxo (LOXO) and Bayer's (BAYRY) Vitrakvi, Stifel analyst Stephen Willey said Bayer's reported price of $393,600/year is likely to generate some debate as it "appears to be breaking the small molecule oncology drug pricing paradigm." However, Willey believes the pricing decision is justified since Vitrakvi "has also shattered the efficacy paradigm for targeted oncology therapy." The $32,800/month price tag, according to media reports, is more than twice his launch pricing estimate, noted Willey, who said he must revisit his modeling assumptions. He has a Buy rating and $230 price target on Loxo Oncology shares.
11/28/18
SBSH
11/28/18
NO CHANGE
Target $201
SBSH
Buy
Loxo Oncology price target lowered to $201 from $213 at Citi
Citi analyst Yigal Nochomovitz lowered his price target for Loxo Oncology to $201 from $213 while keeping a Buy rating on the shares. The analyst says that with the adult price-point of $32,800 for Vitrakvi appearing the highest announced-to-date for a targeted/precision cancer therapy, he removed his estimate for 5% year-over-year price increases.

TODAY'S FREE FLY STORIES

OZM

Och-Ziff Capital

$12.35

1.11 (9.88%)

13:01
01/17/19
01/17
13:01
01/17/19
13:01
Periodicals
Och-Ziff Capital's European equities chief Croxson leaving, FT says »

One of Och-Ziff's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSX

CSX

$64.29

-1.07 (-1.64%)

12:59
01/17/19
01/17
12:59
01/17/19
12:59
Recommendations
CSX analyst commentary  »

Loop Capital positive on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

SLB

Schlumberger

$41.19

-0.02 (-0.05%)

, VFC

VF Corp.

$72.55

0.6 (0.83%)

12:58
01/17/19
01/17
12:58
01/17/19
12:58
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

SLB

Schlumberger

$41.19

-0.02 (-0.05%)

VFC

VF Corp.

$72.55

0.6 (0.83%)

STT

State Street

$70.11

-0.38 (-0.54%)

STI

SunTrust

$57.48

0.12 (0.21%)

CFG

Citizens Financial

$33.71

-0.23 (-0.68%)

RF

Regions Financial

$15.43

0.035 (0.23%)

KSU

Kansas City Southern

$102.88

0.94 (0.92%)

FHN

First Horizon

$14.69

-0.005 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

  • 10

    Feb

  • 11

    Feb

  • 18

    Apr

  • 28

    May

NFLX

Netflix

$352.51

1.36 (0.39%)

, AXP

American Express

$99.27

-0.13 (-0.13%)

12:58
01/17/19
01/17
12:58
01/17/19
12:58
Earnings
Notable companies reporting after market close »

Notable companies…

NFLX

Netflix

$352.51

1.36 (0.39%)

AXP

American Express

$99.27

-0.13 (-0.13%)

PBCT

People's United

$15.86

0.13 (0.83%)

OZK

Bank OZK

$27.41

-0.03 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 18

    Jan

  • 24

    Jan

  • 03

    Mar

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$261.61

0.66 (0.25%)

12:58
01/17/19
01/17
12:58
01/17/19
12:58
Periodicals
Pelosi says House will vote on more shutdown bills next week, WSJ says »

House Speaker Nancy…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$261.61

0.66 (0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:55
01/17/19
01/17
12:55
01/17/19
12:55
General news
Treasury Option Action: leading put strike »

Treasury Option Action:…

12:55
01/17/19
01/17
12:55
01/17/19
12:55
Conference/Events
Stephens construction analysts to hold an analsyt/industry conference call »

Analysts, along with…

TDG

TransDigm

$349.46

0.84 (0.24%)

, ESL

Esterline

$121.88

0.11 (0.09%)

12:55
01/17/19
01/17
12:55
01/17/19
12:55
Conference/Events
Esterline to host special shareholder meeting »

Special Shareholder…

TDG

TransDigm

$349.46

0.84 (0.24%)

ESL

Esterline

$121.88

0.11 (0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 07

    Feb

C

Citi

$62.10

-0.08 (-0.13%)

12:50
01/17/19
01/17
12:50
01/17/19
12:50
Options
Third large call butterfly spread in the big cap banking names Thursday »

Third large call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 11

    Feb

  • 15

    Apr

  • 28

    May

  • 13

    Jul

LION

Fidelity Southern

$28.41

-0.16 (-0.56%)

12:48
01/17/19
01/17
12:48
01/17/19
12:48
Earnings
Fidelity Southern reports Q4 EPS 36c, consensus 33c »

Total assets decreased by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$49.50

0.37 (0.75%)

12:45
01/17/19
01/17
12:45
01/17/19
12:45
Options
Bristol Myers Squibb call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 28

    Jan

  • 28

    Feb

  • 18

    May

  • 20

    May

12:45
01/17/19
01/17
12:45
01/17/19
12:45
General news
Treasury's $13 B 10-year TIPS preview: the auction may suffer »

Treasury's $13 B…

FOSL

Fossil

$17.50

0.09 (0.52%)

, GOOG

Alphabet

$1,080.85

0.63 (0.06%)

12:44
01/17/19
01/17
12:44
01/17/19
12:44
Hot Stocks
Breaking Hot Stocks news story on Fossil, Alphabet, Alphabet Class A »

Fossil jumps 7.6% after…

FOSL

Fossil

$17.50

0.09 (0.52%)

GOOG

Alphabet

$1,080.85

0.63 (0.06%)

GOOGL

Alphabet Class A

$1,090.00

1.17 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 04

    Feb

  • 04

    Feb

  • 25

    Feb

  • 03

    Mar

RTN

Raytheon

$161.77

2.4 (1.51%)

12:32
01/17/19
01/17
12:32
01/17/19
12:32
Hot Stocks
Raytheon awarded $434M contract modification for SPY-6 AIM-9X tactical missiles »

Raytheon Company was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,079.92

-0.3 (-0.03%)

, FOSL

Fossil

$17.50

0.09 (0.52%)

12:31
01/17/19
01/17
12:31
01/17/19
12:31
Hot Stocks
Fossil to sell select smartwatch technology to Google for $40M »

Fossil Group (FOSL)…

GOOG

Alphabet

$1,079.92

-0.3 (-0.03%)

FOSL

Fossil

$17.50

0.09 (0.52%)

GOOGL

Alphabet Class A

$1,089.70

0.87 (0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 04

    Feb

  • 04

    Feb

  • 25

    Feb

  • 03

    Mar

JPM

JPMorgan

$102.54

0.06 (0.06%)

12:30
01/17/19
01/17
12:30
01/17/19
12:30
Options
Call butterfly in JP Morgan is similar to one in Wells Fargo »

Call butterfly in JP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

PHG

Philips

$35.40

(0.00%)

12:29
01/17/19
01/17
12:29
01/17/19
12:29
Periodicals
Philips to shutter U.K. factory as Brexit concerns intensify, Bloomberg says »

Royal Philips intends to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMFA

LM Funding

$2.19

0.765 (53.87%)

12:27
01/17/19
01/17
12:27
01/17/19
12:27
Hot Stocks
LM Funding spikes 53% after completing IIU acquisition, sees accretion in 2019 »

Earlier on Thursday, LM…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NWSA

News Corp.

$12.42

0.03 (0.24%)

12:25
01/17/19
01/17
12:25
01/17/19
12:25
Upgrade
News Corp. rating change  »

News Corp. upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDC

First Data

$22.17

0.9 (4.23%)

12:25
01/17/19
01/17
12:25
01/17/19
12:25
Options
First Data call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

BLK

BlackRock

$410.20

-2.65 (-0.64%)

12:25
01/17/19
01/17
12:25
01/17/19
12:25
Periodicals
BlackRock CEO calls on business leaders to tackle social issues, FT says »

BlackRock CEO Larry Fink…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 29

    Jan

  • 11

    Feb

MS

Morgan Stanley

$42.66

-1.82 (-4.09%)

, AAPL

Apple

$154.13

-0.75 (-0.48%)

12:22
01/17/19
01/17
12:22
01/17/19
12:22
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks opened in negative…

MS

Morgan Stanley

$42.66

-1.82 (-4.09%)

AAPL

Apple

$154.13

-0.75 (-0.48%)

JNJ

Johnson & Johnson

$128.65

0.65 (0.51%)

SHLD

Sears

$0.00

(0.00%)

SBNY

Signature Bank

$120.40

7.98 (7.10%)

MTB

M&T Bank

$161.77

7.32 (4.74%)

SIG

Signet Jewelers

$25.63

-7.745 (-23.21%)

WDC

Western Digital

$35.97

-1.83 (-4.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 22

    Jan

  • 24

    Jan

  • 27

    Jan

  • 29

    Jan

  • 07

    Feb

  • 18

    Feb

LPCN

Lipocine

$2.24

0.65 (40.88%)

12:17
01/17/19
01/17
12:17
01/17/19
12:17
Recommendations
Lipocine analyst commentary  »

Ladenburg reiterates Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
01/17/19
01/17
12:17
01/17/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMB

Limbach Holding

$5.00

(0.00%)

12:16
01/17/19
01/17
12:16
01/17/19
12:16
Hot Stocks
Limbach awarded contracts totaling $81.4M for hospital construction »

Limbach Holdings provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.